Literature DB >> 16772150

Diagnosis of hyperandrogenism: biochemical criteria.

Frank Z Stanczyk1.   

Abstract

Biochemical derangements in ovarian, adrenal, and peripheral androgen production and metabolism play an important role in underlying causes of hyperandrogenism. Specific diagnostic serum markers such as testosterone (total) and dehydroepiandrosterone sulfate (DHEAS), respectively, may be helpful in the diagnosis of ovarian and adrenal hyperandrogenism, respectively. Validated immunoassays or mass spectrometry assays should be used to quantify testosterone, DHEAS and other principal androgens. Free testosterone measurements, determined by equilibrium dialysis or the calculated method, are advocated for routine evaluation of more subtle forms of hyperandrogenism. The skin, with its pilosebaceous units (PSUs), is an important site of active androgen production. A key regulator in PSUs is 5alpha-reductase, which transforms testosterone or androstenedione to dihydrotestosterone (DHT). DHT in blood is not effective in indicating the presence of hyperandrogenism. However, distal metabolites of DHT have been shown to be good markers of clinical manifestations of hirsutism, acne and alopecia. Assays for these peripheral markers need improvement for routine clinical testing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772150     DOI: 10.1016/j.beem.2006.03.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  10 in total

1.  Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.

Authors:  Micol S Rothman; Nichole E Carlson; Mei Xu; Christina Wang; Ronald Swerdloff; Paul Lee; Victor H H Goh; E Chester Ridgway; Margaret E Wierman
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

Review 2.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

Review 3.  Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.

Authors:  Ki Park; Janet Wei; Margo Minissian; C Noel Bairey Merz; Carl J Pepine
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

4.  Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.

Authors:  Manilka Sumanatilleke; Nipun Lakshitha de Silva; Gayani Ranaweera; Chinthaka Appuhamy; Kanishka Karunaratne; M V Chandu de Silva
Journal:  BMC Womens Health       Date:  2022-07-17       Impact factor: 2.742

5.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

6.  Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

Authors:  D Micic; M Sumarac-Dumanovic; A Kendereski; G Cvijovic; S Zoric; D Pejkovic; J Micic; N Milic; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

7.  Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia.

Authors:  Izabela Urysiak-Czubatka; Małgorzata L Kmieć; Grażyna Broniarczyk-Dyła
Journal:  Postepy Dermatol Alergol       Date:  2014-09-08       Impact factor: 1.837

8.  Is There Any Association Between Clinical and Biochemical Hyperandrogenism in Women With Female Pattern Hair Loss?

Authors:  Samih A Odhaib; Khalil Al Hamdi; Abbas A Mansour
Journal:  Cureus       Date:  2020-11-27

9.  Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study.

Authors:  Gurhan Guney; Mine Islimye Taskin; Ozgur Baykan; Ertan Adali; Selin Gul Tezcan; Serkan Sarikaya; Cihan Kaya; Ezgi Tolu
Journal:  Ther Adv Endocrinol Metab       Date:  2021-10-08       Impact factor: 3.565

10.  Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women.

Authors:  Yasir S Elhassan; Jan Idkowiak; Karen Smith; Miriam Asia; Helena Gleeson; Rachel Webster; Wiebke Arlt; Michael W O'Reilly
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.